Medicine and Dentistry
Peripheral Nervous System
100%
Patient
100%
Neurological Complication
80%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Methotrexate
20%
Cyclosporine
20%
Reduced Intensity Conditioning
20%
Mortality
20%
Inpatient
20%
Follow up
10%
Toxicity
10%
Low Drug Dose
10%
Transplantation
10%
Prophylaxis
10%
Overall Survival
10%
Cumulative Incidence
10%
Bleeding
10%
Mycophenolate Mofetil
10%
Brain Disease
10%
Apoplexy
10%
Graft Versus Host Reaction
10%
Polyneuropathy
10%
Cyclophosphamide
10%
Busulfan
10%
Whole Body Radiation
10%
Meningoencephalitis
10%
Chemotherapeutic Agent
10%
Allogeneic Stem Cell Transplantation
10%
Fludarabine
10%
Melphalan
10%
Life
10%
Drug
10%
Mononeuropathy
10%
Incidence
10%
Blood
10%
Nursing and Health Professions
Neurological Complication
80%
Complication
30%
Methotrexate
20%
Mortality
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Reduced Intensity Conditioning
20%
Follow up
10%
Confidence Interval
10%
Mycophenolate Mofetil
10%
Prophylaxis
10%
Transplantation
10%
Bleeding
10%
Toxicity
10%
Overall Survival
10%
Low Drug Dose
10%
Busulfan
10%
Fludarabine
10%
Allogeneic Stem Cell Transplantation
10%
Melphalan
10%
Brain Disease
10%
Cyclophosphamide
10%
Procedures
10%
Incidence
10%
Drug
10%
Polyneuropathy
10%
Whole Body Radiation
10%
Meningoencephalitis
10%
Mononeuropathy
10%
Biochemistry, Genetics and Molecular Biology
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Incidence
20%
Mortality
20%
Conditioning
20%
Low Drug Dose
10%
Overall Survival
10%
Methotrexate
10%
Busulfan
10%
Allogeneic Stem Cell Transplantation
10%
Melphalan
10%
Fludarabine
10%
Cyclophosphamide
10%
Host
10%
Life
10%
Neuroscience
Methotrexate
20%
Ciclosporin
20%
Mycophenolate Mofetil
10%
Polyneuropathy
10%
Meningoencephalitis
10%
Cyclophosphamide
10%
Fludarabine
10%
Melphalan
10%
Busulfan
10%
Stroke
10%
Encephalopathy
10%
Pharmacology, Toxicology and Pharmaceutical Science